Search research articles
Contact Us
Filters
Showing results (171-180 of 224) with videos related to
Page
of 23
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614
Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Gynecologic Oncology
|
July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203
Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2025
"Hope" Drives Quality of Life in Patients With Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003
Benjamin W Corn, Rebecca Paulus, Vinai Gondi, et al.
Cell Reports
|
May 18, 2017
The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands
Hugo G Hilton, Curtis P McMurtrey, Alex S Han, et al.
Advances in Radiation Oncology
|
September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
Canhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
The Prostate
|
July 21, 2025
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
Emily Chan, Stephanie L Pugh, Jeffry P Simko, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2025
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors
Thomas J Galloway, Stephanie L Pugh, John A Ridge, et al.
The New England Journal of Medicine
|
April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
Ethan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy
Himanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 224) with videos related to
Sort By:
Page
of 23
International Journal of Radiation Oncology, Biology, Physics
|
December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614
Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Gynecologic Oncology
|
July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203
Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 4, 2025
"Hope" Drives Quality of Life in Patients With Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003
Benjamin W Corn, Rebecca Paulus, Vinai Gondi, et al.
Cell Reports
|
May 18, 2017
The Intergenic Recombinant HLA-B∗46:01 Has a Distinctive Peptidome that Includes KIR2DL3 Ligands
Hugo G Hilton, Curtis P McMurtrey, Alex S Han, et al.
Advances in Radiation Oncology
|
September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
Canhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
The Prostate
|
July 21, 2025
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy
Emily Chan, Stephanie L Pugh, Jeffry P Simko, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 5, 2025
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related Factors
Thomas J Galloway, Stephanie L Pugh, John A Ridge, et al.
The New England Journal of Medicine
|
April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
Ethan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy
Himanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.
Page
of 23